Tag: Bharat Biotech
Bharat Biotech celebrates 3 decades of scientific excellence and global vaccine...
Over the past 30 years, Bharat Biotech has grown from a single facility in Hyderabad into a global vaccine powerhouse
Biofabri, Bharat Biotech sign tech transfer deal for TB vaccine MTBVAC
MTBVAC represents a critically important advance in global TB prevention, as it’s one of two vaccine candidates that have progressed into advanced clinical development.
Bharat Biotech–GSK partnership slashes price of world’s first malaria vaccine for...
Price reduction driven by process improvements, expanded production capacity, cost-effective manufacturing, and minimal profit margins
Bharat Biotech to advance development of GSK’s Shigella vaccine candidate for...
The company in-licenses altSonflex1-2-3, a promising Shigella vaccine candidate, from GSK for continued clinical development and scale-up
Dr Suchitra K. Ella elected as CII Vice President for 2025-26
Mrs Ella co-founded Bharat Biotech with Dr Krishna Ella in 1996
Bharat Biotech enters gene & cell therapies segment, launches India’s only...
The 50,000-square-foot dedicated state-of-the-art CGT facility represents the next milestone in BBIL’s long-standing mission to deliver targeted, life-saving treatments
CDSCO grants approval to Biovet’s BIOLUMPIVAXIN, first Indian & global DIVA...
Developed in collaboration with ICAR, BIOLUMPIVAXIN® is also India’s first LSD Vaccine
Singapore President visits Sapigen Biologix, a Bharat Biotech subsidiary built at...
The state-of-the-art vaccine manufacturing plant is built to produce 10 different vaccines, and create more than 2000 direct jobs and 1500 indirect employment opportunities
Dr Krishna Ella bestowed with INSA India Fellowship 2025
Bharat Biotech's Founder & Executive Chairman has been recognized for his contributions to new knowledge, discoveries and development of new vaccine technologies
“Indian vaccine industry has a promising future”
Dr Krishna Ella, Executive Chairman, Bharat Biotech and President, IVMA shares his insights on the industry’s journey so far and the future potential.